Total Clarity Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-160
Closed -$33K – 296
2022
Q2
$33K Buy
+160
New +$32.7K 0.02% 476
2022
Q1
– Sell
-135
Closed -$32K – 282
2021
Q4
$32K Hold
135
– – 0.01% 476
2021
Q3
$38K Buy
+135
New +$44.2K 0.02% 443
2021
Q2
– Sell
-135
Closed -$38K – 246
2021
Q1
$38K Buy
+135
New +$36.4K 0.02% 373
2020
Q1
– Sell
-135
Closed -$40K – 138
2019
Q4
$40K Buy
+135
New +$37.5K 0.03% 297

Other funds holding BIIB

Total Clarity Wealth Management's BIIB Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Biogen (BIIB) in Q3 2022, closing a stake of 160 shares — an estimated $33K sold.

Total Clarity Wealth Management first reported a position in BIIB in Q4 2019 and held it in 5 quarters. The position peaked at $40K in Q4 2019. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 160 Biogen shares in Q3 2022, an estimated $33K.
  • Total Clarity Wealth Management first reported a position in Biogen in Q4 2019 and held it in 5 quarters.
  • Total Clarity Wealth Management's Biogen position peaked at $40K in Q4 2019.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.